Hrt Financial LP Renovacor, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $2.18 $7,123 - $129,411	-59,363 Reduced 64.75%	32,319 $81,000
Q2 2022 Aug 12, 2022	SELL	$1.56 - $4.29 $17,490 - $48,099	-11,212 Reduced 10.9%	91,682 $185,000
Q1 2022 May 16, 2022	SELL	$4.02 - $8.23 $57,968 - $118,676	-14,420 Reduced 12.29%	102,894 $436,000
Q4 2021 Feb 14, 2022	SELL	$6.99 - $9.39 $58,590 - $78,706	-8,382 Reduced 6.67%	117,314 $903,000
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $971,630 - $1.34 Million	125,696 New	125,696 $1.14 Million

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.